During the past year, scientists have made incredible leaps in diagnosing and treating Lyme disease. We’ve seen a realistic vaccine candidate emerge and several new and exciting treatments with exciting
Read more
84% of patients referred for Lyme disease treatment at a US facility had “no findings of active Lyme disease,” a new study has found. Instead, the majority of patients were
Read more
Yale University scientists have developed a novel vaccine that offers protection against Lyme disease-causing bacteria and other tick-borne diseases. Using the same mRNA technology in COVID-19 vaccines, the vaccine has
Read more
Researchers have identified an exciting new antibiotic that shows excellent potential in treating Lyme disease and eradicating it from the environment. In a recent paper published in the journal Cell,
Read more
Over half (55%) of all “long Covid” patients reported fatigue up to six months after the initial infection researchers have found. The Centers for Disease Control and Prevention estimates that
Read more
Pfizer and Valneva have released promising results from the Phase 2 clinical trial of their new Lyme disease vaccine, VLA15. While an antibody response remained in all groups after month
Read more
At Biocentaur, we stay at the cutting edge of new development in diagnosing and treating Lyme disease. Our range of genetic tests is helping patients receive a fast and accurate
Read more
Researchers for Germany’s Uppsala University have found that a simple genetic test can identify patients at risk of experiencing cardiovascular and inflammatory diseases more accurately than current approaches. Analysing over
Read more
At Biocentaur, we stay at the cutting edge of new developments in diagnosing and treating Lyme disease. Our range of genetic tests is helping patients receive a fast and accurate
Read more
Up to 60% of US travellers who contracted salmonella abroad were resistant to fluoroquinolones; a common antibiotic used to treat the condition, US scientists have discovered. The findings highlight the
Read more
